Drug Manufacturers’ Delayed Disclosure of Serious and Unexpected Adverse Events to the U.S. Food and Drug Administration

By Paul MaPinar Karaca-Mandic
JAMA Internal Medicine
2015 Vol. 175 Issue 9 Pages 1565-1566.